Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05172141
What this trial is testing

A Safety, Tolerability, and Efficacy Study of IBI314 in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Innovent Biologics (Suzhou) Co. Ltd. 222
Testing effectiveness (Phase 2)Study completedNCT04709835
What this trial is testing

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

Who this might be right for
COVID-19
Hoffmann-La Roche 104
Testing effectiveness (Phase 2)Study completedNCT04475107
What this trial is testing

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Who this might be right for
COVID-19
Shin Poong Pharmaceutical Co. Ltd. 113
Not applicableStudy completedNCT06974058
What this trial is testing

Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms

Who this might be right for
Long COVID
Liaquat University of Medical & Health Sciences 15
Not applicableStudy completedNCT04966013
What this trial is testing

Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

Who this might be right for
COVID19
EmitBio Inc. 216
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Testing effectiveness (Phase 2)Ended earlyNCT05124210
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 8
Not applicableUnknownNCT05366205
What this trial is testing

Immune Function in Elderly Patients With Mild to Moderate COVID-19 on Hemodialysis

Who this might be right for
COVID-19Hemodiafiltration
Ruijin Hospital 112
Testing effectiveness (Phase 2)Ended earlyNCT05166876
What this trial is testing

Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Clear Creek Bio, Inc. 26
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Early research (Phase 1)WithdrawnNCT05596045
What this trial is testing

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

Who this might be right for
SARS CoV 2 Infection
Ascletis Pharmaceuticals Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT04676867
What this trial is testing

Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19

Who this might be right for
Covid19
DalCor Pharmaceuticals 227
Testing effectiveness (Phase 2)Study completedNCT04780321
What this trial is testing

JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects

Who this might be right for
COVID-19
Shanghai Junshi Bioscience Co., Ltd. 62
Not applicableStudy completedNCT06695377
What this trial is testing

Thromboembolic Complications in Mild Covid-19 Cases

Who this might be right for
COVID 19Thromboembolic and Bleeding ComplicationsThromboembolism, Venous+1 more
Marmara University Pendik Training and Research Hospital 961
Large-scale testing (Phase 3)Ended earlyNCT04822701
What this trial is testing

Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19

Who this might be right for
COVID-19
Boehringer Ingelheim 5
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Not applicableUnknownNCT04643054
What this trial is testing

Efficacy and Safety of Ovotransferrin in COVID-19 Patients

Who this might be right for
Covid19
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 100
Testing effectiveness (Phase 2)WithdrawnNCT04398290
What this trial is testing

INOPulse for COVID-19

Who this might be right for
COVID-19HypoxemiaHypoxemic Respiratory Failure
Roger Alvarez
Not applicableStudy completedNCT04414124
What this trial is testing

A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19

Who this might be right for
Mild-to-moderate COVID-19
Kaleido Biosciences 350
Testing effectiveness (Phase 2)Study completedNCT04891302
What this trial is testing

The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19

Who this might be right for
COVID-19
Bukwang Pharmaceutical 104
Next Page